Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kenneth F. Grossmann"'
Autor:
Brian R. Gastman, Martin D. Fleming, Anthony J. Olszanski, Jeffrey A. Sosman, Samantha Guild, April K.S. Salama, Susan M. Swetter, Dominick J. DiMaio, Douglas B. Johnson, Richard W. Joseph, Ryan M. Lanning, Rohit Sharma, Joseph J. Skitzki, Anjela Galan, Alison B. Durham, Anita M. Engh, Joel M. Baumgartner, Kenneth F. Grossmann, Genevieve M. Boland, Kari Kendra, Bartosz Chmielowski, Patrick A. Ott, Mark R. Albertini, Giorgos C. Karakousis, Kim Margolin, Nicole R. McMillian, Julie R. Lange, Merrick I. Ross, Christopher A. Barker, Evan Wuthrick, John A. Thompson, Ryan C. Fields, Ashley M. Holder
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:364-376
Over the past few years, the NCCN Guidelines for Melanoma: Cutaneous have been expanded to include pathways for treatment of microscopic satellitosis (added in v2.2020), and the following Principles sections: Molecular Testing (added in v2.2019), Sys
Autor:
Elizabeth I. Buchbinder, Catrina Mireles, Megan Othus, William E. Carson, Michael C. Lowe, Sapna Pradyuman Patel, Elad Sharon, Michael T. Tetzlaff, Antoni Ribas, Samantha R. Guild, Kenneth F. Grossmann, Vernon K. Sondak, James C. Moon, Larissa A. Korde
Publikováno v:
Journal of Clinical Oncology. 39:TPS9585-TPS9585
TPS9585 Background: Although long term outcomes for most patients with early-stage melanoma is excellent following surgery, patients who have high-risk features such as lymph node involvement have poorer outcomes. Adjuvant therapy (AT) is currently c
Autor:
Justin C. Sowder, Marcus M. Monroe, Luke O. Buchmann, Ying J. Hitchcock, Kenneth F. Grossmann, Shane Lloyd, Jason P. Hunt, Richard B. Cannon
Publikováno v:
Head & Neck. 39:876-880
Background National guidelines support both surgical and radiotherapy (RT) as initial treatment options for early-stage oral cavity squamous cell carcinoma (SCC). There remains limited data evaluating the survival outcomes of RT and the current pract
Autor:
Michael C. Lowe, Antoni Ribas, Elizabeth I. Buchbinder, Danae Campos, Megan Othus, William E. Carson, Kenneth F. Grossmann, Elad Sharon, Larissa A. Korde, Michael T. Tetzlaff, Sapna Pradyuman Patel, James C. Moon, Vernon K. Sondak
Publikováno v:
Journal of Clinical Oncology. 38:TPS10090-TPS10090
TPS10090 Background: Although long term outcomes for most patients with early-stage melanoma is excellent following surgery, patients who have high-risk features such as lymph node involvement have poorer outcomes. Adjuvant therapy (AT) is currently
Autor:
Kenneth F. Grossmann, David A. Wada, Douglas Grossman, Kenneth M. Boucher, Ying J. Hitchcock, Glen M. Bowen, Sheri L. Holmen, Hung Khong, Morgan Ward, John R. Hyngstrom, Gita Suneja, Adam L. Cohen, Laura J. Gardner, Martin McMahon, Robert H.I. Andtbacka, Marcus M. Monroe, Carolyn Ross, Tawnya L. Bowles
Melanoma metastasis to the brain is associated with a poor prognosis. We sought to determine patient demographics and primary tumor factors associated with the development of brain metastasis (BM) and survival. We also investigated whether the BM det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c88ec5e683bb601afbdc7b7a58e2ab8
https://europepmc.org/articles/PMC5583702/
https://europepmc.org/articles/PMC5583702/
Autor:
Dennis C. Shrieve, R. Dirk Noyes, Ying J. Hitchcock, Breanne E. Terakedis, Glen M. Bowen, Kenneth M. Boucher, Kenneth F. Grossmann, William T. Sause, Christopher J. Anker, Sancy A. Leachman, Tawnya L. Bowles, Robert H.I. Andtbacka
Publikováno v:
Journal of the American Academy of Dermatology. 70:435-442
Background Patients with melanoma of the scalp may have higher failure (recurrence) rates than melanoma of other body sites. Objective We sought to characterize survival and patterns of failure for patients with scalp melanoma. Methods Between 1998 a
Autor:
Ricardo J. Gonzalez, Joseph Markowitz, Jonathan S. Zager, Wayne Cruse, Andrew S. Brohl, Michael A. Harrington, Jennifer Cisneros, Vernon K. Sondak, Zeynep Eroglu, Nikhil I. Khushalani, Nalan Akgul Babacan, Kenneth F. Grossmann, Amod A. Sarnaik
Publikováno v:
Journal of Clinical Oncology. 37:9590-9590
9590 Background: Until recently, most patients (pts) with SLN+ MEL underwent CLND, a procedure mandated in published trials of adjuvant anti-PD-1 therapy to date. Following MSLT-II, this practice has dramatically changed with most pts now undergoing
Autor:
Samuel C. Blackman, Stanley W. Carson, Noelia Nebot, Sunil Sharma, Patricia LoRusso, Elizabeth C. Krachey, Kenneth F. Grossmann, Daniele Ouellet, Jeffrey R. Infante, Michael S. Gordon
Publikováno v:
Cancer Research. 72:3766-3766
GSK2118436 is a potent and selective small-molecule inhibitor of BRAF kinase activity that is currently being developed for the treatment of BRAF mutation-positive tumors. This study evaluated the effect of a high-fat meal on the pharmacokinetics (PK
Autor:
Robert H.I. Andtbacka, Breanne E. Terakedis, Kenneth F. Grossmann, Dennis C. Shrieve, Christopher J. Anker, Glen M. Bowen
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 81:S688